Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-21

FDA Approved: DARIFENACIN — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for Darifenacin from Torrent Pharmaceuticals Limited, expanding access to this overactive bladder therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darifenacin (darifenacin)

Snippet

SUPPL AP for DARIFENACIN (DARIFENACIN)